Novanta to Acquire Riverpoint Medical for $1.2 Billion Upfront to Enter Minimally Invasive Surgery Market

Ropes & Gray advised Novanta, a leading global supplier of core technologies for medical, life sciences and industrial original equipment manufacturers, in an agreement to acquire Riverpoint Medical, a leader in minimally invasive surgical consumables, from Arlington Capital Partners for up to $1.45 billion. The transaction was announced on June 9.

Under the agreement, Novanta will acquire all outstanding equity interests of the parent company of Riverpoint Medical for an upfront cash payment of $1.2 billion and a milestone payment of $250 million in the first quarter of 2027. The transaction is expected to close in the third quarter of 2026.

Riverpoint Medical is a developer, designer and manufacturer of medical devices focused on surgical fibers and related technologies, providing OEMs with minimally invasive surgical instruments for markets in sports medicine, trauma and cardiovascular surgery.

The Ropes & Gray team was led by mergers & acquisitions partner Matt Byron and included mergers & acquisitions associate Debbie Wang, IP transactions partners Melissa Rones and Emily Karlberg, employment, executive compensation & benefits partner Renata Ferrari, tax partner Pamela Glazier, litigation & enforcement partners Samer Musallam, Lisa Kaltenbrunner, and Emerson Siegle, private equity partner Deidre Johnson, IP transactions counsel Ryan Murphey, executive compensation & benefits counsel Rebecca Liu, and litigation & enforcement counsel Heather Sprague, Alison McLaughlin, and Kurt Fowler.